MELOXICAM TABLETS
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
Defense Logistics Agency award SPE2DP27F0339, issued under delivery order SPE2DX25D9900, designates DMS Pharmaceutical Group Inc as the provider for Meloxicam Tablets. This federal contract, managed by the DLA Troop Support Medical Supply Chain, involves the procurement of three bottles of medication at a unit price of 45.00, resulting in a total contract value of 135.00. The agreement specifies a delivery date of October 27, 2026, with shipping terms set as FOB Destination to the US Army SSA in Powidz, Poland. This award is linked to base contract SPE2DX25D9000 and replaces previous contract SPE2DX25D9383, incorporating standard federal acquisition regulations and referencing solicitation SPE2DX-24-R-0001.
General Info
Contract Value
$135Place of Performance
Not specifiedSet-Aside
Awardee
DMS PHARMACEUTICAL GROUP INCAward Issued Date
Documents
2AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Earlier notices in this NAICS code
Posted before this notice, open and closed
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
